Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.

Suppr

超能文献

作者信息

Bhatti R A, Ablin R J, Guinan P D, Totonchi E, Zamora S

出版信息

Experientia. 1978 Oct 15;34(10):1364-5. doi: 10.1007/BF01981475.

DOI:10.1007/BF01981475

PMID:738427

Abstract

摘要

相似文献

Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.

Experientia. 1978 Oct 15;34(10):1364-5. doi: 10.1007/BF01981475.

Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.雌激素对免疫反应性的调节作用。II. 前列腺癌患者肿瘤相关免疫的抑制

Clin Exp Immunol. 1979 Oct;38(1):83-91.

Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.

Cancer Res. 1978 Nov;38(11 Pt 1):3702-6.

Immunomodulatory effects of oestrogen in prostatic cancer: update and further consideration.

Allergol Immunopathol (Madr). 1981 Jan-Feb;9(1):63-70.

Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer.

Am J Reprod Immunol (1980). 1981 Aug;1(4):206-9. doi: 10.1111/j.1600-0897.1981.tb00038.x.

Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostate.

J Reprod Immunol. 1980 Feb;1(5-6):337-45. doi: 10.1016/0165-0378(80)90007-8.

Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibition.前列腺癌患者临床管理中细胞免疫反应性的评估。IV. 白细胞黏附抑制。

Urol Int. 1976;31(6):459-69. doi: 10.1159/000280081.

Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor.

Eur J Cancer (1965). 1977 Jul;13(7):699-703. doi: 10.1016/0014-2964(77)90056-1.

Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.

Eur J Cancer (1965). 1979 Jan;15(1):133-6. doi: 10.1016/0014-2964(79)90215-9.

Cell-mediated immunity in prostatic cancer.前列腺癌中的细胞介导免疫。

Clin Oncol. 1980 Sep;6(3):253-64.

本文引用的文献

The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes.雌激素对PHA刺激的人外周血淋巴细胞掺入3H-胸腺嘧啶核苷的影响。

J Immunol. 1974 Aug;113(2):705-7.

Antiandrogenic suppression of lymphocytic blastogenesis: in vitro and in vivo observations.抗雄激素对淋巴细胞增殖的抑制作用：体内外观察

Experientia. 1974 Nov 15;30(11):1351-3. doi: 10.1007/BF01945224.

Hormonal therapy and alteration of lymphocyte proliferation.

J Lab Clin Med. 1976 Feb;87(2):227-31.

Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.通过试管内抗原诱导的白细胞黏附抑制评估乳腺癌患者的细胞介导抗肿瘤免疫。

Cancer Res. 1975 Sep;35(9):2571-9.

Hormonal epidemiology of prostatic cancer.

Med J Aust. 1977 Mar 26;1(13):462-4. doi: 10.5694/j.1326-5377.1977.tb130815.x.

Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor.

Eur J Cancer (1965). 1977 Jul;13(7):699-703. doi: 10.1016/0014-2964(77)90056-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验